APO RESEARCH · REPORT
Alvimopan
Alvimopan, CAS 156053-89-3, (trade name Entereg) is a drug, which behaves as a peripherally acting μ-opioid receptor antagonist. It is currently only Food and Drug Administration approved for the treatment of postoperative ileus, which it received in May 2008.
Product & engineering
Understand the product.
Alvimopan, CAS 156053-89-3, (trade name Entereg) is a drug, which behaves as a peripherally acting μ-opioid receptor antagonist. It is currently only Food and Drug Administration approved for the treatment of postoperative ileus, which it received in May 2008.
Selected research
Industry Research
Alvimopan Industry Research Report 2026
Market perspective
Alvimopan, CAS 156053-89-3, (trade name Entereg) is a drug, which behaves as a peripherally acting μ-opioid receptor antagonist. It is currently only Food and Drug Administration approved for the treatment of postoperative ileus, which it received in May 2008.
Alvimopan (CAS 156053-89-3) is widely used in Pharmaceutical and Other field. The most proportion of Alvimopan (CAS 156053-89-3) is used in Pharmaceutical, and the proportion in 2019 is 88.64%. Market competition is intense. Merck is the leaders of the industry, and they hold key technologies and patents, with high-end customers.
Report Scope
Read the full market overview
This report quantifies the global Alvimopan market in terms of revenue (US$ million) and, where applicable, sales volume (KG), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/KG) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Alvimopan Market by Company
Merck
Teva Pharmaceutical Industries Ltd
MSN Life Sciences Private Ltd
Alvimopan Segment by Type
Pharmaceutical Grade
Others
Alvimopan Segment by Application
Pharmaceutical
Other
Alvimopan Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alvimopan market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Alvimopan and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alvimopan.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Alvimopan manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Alvimopan by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Alvimopan in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Pharmaceutical Grade
- Others
Applications
- Pharmaceutical
- Other
Companies covered
- Merck
- Teva Pharmaceutical Industries Ltd
- MSN Life Sciences Private Ltd
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Alvimopan Market Size (2021-2032)
- 2.2.2 Global Alvimopan Sales (2021-2032)
- 2.2.3 Global Alvimopan Market Average Price (2021-2032)
- 2.3 Alvimopan by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Pharmaceutical Grade
- 2.3.3 Others
- 2.4 Alvimopan by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pharmaceutical
- 2.4.3 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Alvimopan Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Alvimopan Sales (KG) of Manufacturers (2021-2026)
- 3.3 Global Alvimopan Revenue of Manufacturers (2021-2026)
- 3.4 Global Alvimopan Average Price by Manufacturers (2021-2026)
- 3.5 Global Alvimopan Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Alvimopan, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Alvimopan, Product Type & Application
- 3.8 Global Manufacturers of Alvimopan, Established Date
- 3.9 Global Alvimopan Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Merck
- 4.1.1 Merck Company Information
- 4.1.2 Merck Business Overview
- 4.1.3 Merck Alvimopan Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Merck Alvimopan Product Portfolio
- 4.1.5 Merck Recent Developments
- 4.2 Teva Pharmaceutical Industries Ltd
- 4.2.1 Teva Pharmaceutical Industries Ltd Company Information
- 4.2.2 Teva Pharmaceutical Industries Ltd Business Overview
- 4.2.3 Teva Pharmaceutical Industries Ltd Alvimopan Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Teva Pharmaceutical Industries Ltd Alvimopan Product Portfolio
- 4.2.5 Teva Pharmaceutical Industries Ltd Recent Developments
- 4.3 MSN Life Sciences Private Ltd
- 4.3.1 MSN Life Sciences Private Ltd Company Information
- 4.3.2 MSN Life Sciences Private Ltd Business Overview
- 4.3.3 MSN Life Sciences Private Ltd Alvimopan Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 MSN Life Sciences Private Ltd Alvimopan Product Portfolio
- 4.3.5 MSN Life Sciences Private Ltd Recent Developments
5 Global Alvimopan Market Scenario by Region
- 5.1 Global Alvimopan Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Alvimopan Sales by Region: 2021-2032
- 5.2.1 Global Alvimopan Sales by Region: 2021-2026
- 5.2.2 Global Alvimopan Sales by Region: 2027-2032
- 5.3 Global Alvimopan Revenue by Region: 2021-2032
- 5.3.1 Global Alvimopan Revenue by Region: 2021-2026
- 5.3.2 Global Alvimopan Revenue by Region: 2027-2032
- 5.4 North America Alvimopan Market Facts & Figures by Country
- 5.4.1 North America Alvimopan Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Alvimopan Sales by Country (2021-2032)
- 5.4.3 North America Alvimopan Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Alvimopan Market Facts & Figures by Country
- 5.5.1 Europe Alvimopan Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Alvimopan Sales by Country (2021-2032)
- 5.5.3 Europe Alvimopan Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Alvimopan Market Facts & Figures by Country
- 5.6.1 Asia Pacific Alvimopan Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Alvimopan Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Alvimopan Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Alvimopan Market Facts & Figures by Country
- 5.7.1 South America Alvimopan Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Alvimopan Sales by Country (2021-2032)
- 5.7.3 South America Alvimopan Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Alvimopan Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Alvimopan Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Alvimopan Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Alvimopan Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Alvimopan Sales by Type (2021-2032)
- 6.1.1 Global Alvimopan Sales by Type (2021-2032) & (KG)
- 6.1.2 Global Alvimopan Sales Market Share by Type (2021-2032)
- 6.2 Global Alvimopan Revenue by Type (2021-2032)
- 6.2.1 Global Alvimopan Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Alvimopan Revenue Market Share by Type (2021-2032)
- 6.3 Global Alvimopan Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Alvimopan Sales by Application (2021-2032)
- 7.1.1 Global Alvimopan Sales by Application (2021-2032) & (KG)
- 7.1.2 Global Alvimopan Sales Market Share by Application (2021-2032)
- 7.2 Global Alvimopan Revenue by Application (2021-2032)
- 7.2.1 Global Alvimopan Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Alvimopan Revenue Market Share by Application (2021-2032)
- 7.3 Global Alvimopan Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Alvimopan Value Chain Analysis
- 8.1.1 Alvimopan Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Alvimopan Production Mode & Process
- 8.2 Alvimopan Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Alvimopan Distributors
- 8.2.3 Alvimopan Customers
9 Global Alvimopan Analyzing Market Dynamics
- 9.1 Alvimopan Industry Trends
- 9.2 Alvimopan Industry Drivers
- 9.3 Alvimopan Industry Opportunities and Challenges
- 9.4 Alvimopan Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst